UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000001367
Receipt number R000001662
Scientific Title An Open-Label Randomized Phase III Study of Capecitabine(6 months) versus Capecitabine(12 months) as Adjuvant Chemotherapy for Stage III(Dukes'C) Colon Cancer Patients.
Date of disclosure of the study information 2008/09/10
Last modified on 2019/03/18 10:07:42

No. Disposal Last modified on Item of update
1 Insert 2008/09/10 13:21:42
2 Update 2008/09/16 13:05:30 Address
3 Update 2008/09/17 10:17:51 Address
Address
TEL
Address
Address
TEL
Address1
Tel1
4 Update 2008/11/26 15:13:54 Name of person sending information
Name of person sending information
Address
5 Update 2009/03/10 10:17:42 Email
6 Update 2010/01/14 13:51:15 Recruitment status
7 Update 2010/02/08 15:50:41 Narrative objectives1
Key secondary outcomes
Key secondary outcomes
8 Update 2010/02/08 15:51:45 Key inclusion criteria
9 Update 2010/03/19 13:07:46 Public title
Acronym
10 Update 2010/03/19 13:09:54 Condition
Narrative objectives1
11 Update 2010/03/19 13:11:39 Key exclusion criteria
12 Update 2010/03/19 13:13:56 Last name of contact person
Last name of contact person
Address
Email
Name of person sending information
Address
Email
13 Update 2010/03/19 13:14:31 Last follow-up date
14 Update 2010/03/19 13:26:07 Key inclusion criteria
15 Update 2010/03/30 13:17:48 Condition
16 Update 2019/03/18 09:48:52 Recruitment status
Date of IRB
17 Update 2019/03/18 10:07:42 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures